These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 25770841)

  • 21. Oxidant and Inflammatory Mechanisms and Targeted Therapy in Atrial Fibrillation: An Update.
    Gutierrez A; Van Wagoner DR
    J Cardiovasc Pharmacol; 2015 Dec; 66(6):523-9. PubMed ID: 26335221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management and prognosis of atrial fibrillation in diabetic patients: an EORP-AF General Pilot Registry report.
    Fumagalli S; Said SA; Laroche C; Gabbai D; Boni S; Marchionni N; Boriani G; Maggioni AP; Musialik-Lydka A; Sokal A; Petersen J; Crijns HJGM; Lip GYH;
    Eur Heart J Cardiovasc Pharmacother; 2018 Jul; 4(3):172-179. PubMed ID: 29309557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induced diabetic rats.
    Shao Q; Meng L; Lee S; Tse G; Gong M; Zhang Z; Zhao J; Zhao Y; Li G; Liu T
    Cardiovasc Diabetol; 2019 Nov; 18(1):165. PubMed ID: 31779619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Association Between Diabetes Mellitus and Atrial Fibrillation: Clinical and Mechanistic Insights.
    Bohne LJ; Johnson D; Rose RA; Wilton SB; Gillis AM
    Front Physiol; 2019; 10():135. PubMed ID: 30863315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epicardial adipose tissue and atrial fibrillation: pathophysiological mechanisms, clinical implications, and potential therapies.
    Goudis CA; Vasileiadis IE; Liu T
    Curr Med Res Opin; 2018 Nov; 34(11):1933-1943. PubMed ID: 29625530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atrial fibrillation and electrical remodeling: the potential role of inflammation and oxidative stress.
    Korantzopoulos P; Kolettis T; Siogas K; Goudevenos J
    Med Sci Monit; 2003 Sep; 9(9):RA225-9. PubMed ID: 12960937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of aldosterone antagonists on the substrate for atrial fibrillation: aldosterone promotes oxidative stress and atrial structural/electrical remodeling.
    Mayyas F; Alzoubi KH; Van Wagoner DR
    Int J Cardiol; 2013 Oct; 168(6):5135-42. PubMed ID: 23993726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of diabetes mellitus in recovery and maintenance of sinus rhythm in patients with persistent atrial fibrillation].
    Potpara T; Marinković-Erić J; Grujić M; Radojković-Cirović B; Vujisić-Tesić B; Petrović M
    Srp Arh Celok Lek; 2002; 130(5-6):189-92. PubMed ID: 12395441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of NLRP3-Inflammasome/Caspase-1/Galectin-3 Pathway on Atrial Remodeling in Diabetic Rabbits.
    Wu X; Liu Y; Tu D; Liu X; Niu S; Suo Y; Liu T; Li G; Liu C
    J Cardiovasc Transl Res; 2020 Oct; 13(5):731-740. PubMed ID: 32048199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of insulin signaling may contribute to atrial fibrillation and atrial electrical remodeling in type 1 diabetes.
    Polina I; Jansen HJ; Li T; Moghtadaei M; Bohne LJ; Liu Y; Krishnaswamy P; Egom EE; Belke DD; Rafferty SA; Ezeani M; Gillis AM; Rose RA
    Proc Natl Acad Sci U S A; 2020 Apr; 117(14):7990-8000. PubMed ID: 32198206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Type 2 diabetes mellitus and atrial fibrillation: From mechanisms to clinical practice.
    Tadic M; Cuspidi C
    Arch Cardiovasc Dis; 2015 Apr; 108(4):269-76. PubMed ID: 25858534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atrial Fibrillation Is Associated With Impaired Atrial Mitochondrial Energetics and Supercomplex Formation in Adults With Type 2 Diabetes.
    Kanaan GN; Patten DA; Redpath CJ; Harper ME
    Can J Diabetes; 2019 Feb; 43(1):67-75.e1. PubMed ID: 30146472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diabetes mellitus and atrial fibrillation: evidence of a pathophysiological, clinical and epidemiological association beyond the thromboembolic risk].
    Proietti R; Russo V; Wu MA; Maggioni AP; Marfella R
    G Ital Cardiol (Rome); 2017 Mar; 18(3):199-207. PubMed ID: 28398378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wenxin Keli Regulates Mitochondrial Oxidative Stress and Homeostasis and Improves Atrial Remodeling in Diabetic Rats.
    Gong M; Yuan M; Meng L; Zhang Z; Tse G; Zhao Y; Zhang Y; Yuan M; Liang X; Fan G; Yan GX; Li G; Liu T
    Oxid Med Cell Longev; 2020; 2020():2468031. PubMed ID: 32104528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms.
    Andrade J; Khairy P; Dobrev D; Nattel S
    Circ Res; 2014 Apr; 114(9):1453-68. PubMed ID: 24763464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycemic control and atrial fibrillation: an intricate relationship, yet under investigation.
    Papazoglou AS; Kartas A; Moysidis DV; Tsagkaris C; Papadakos SP; Bekiaridou A; Samaras A; Karagiannidis E; Papadakis M; Giannakoulas G
    Cardiovasc Diabetol; 2022 Mar; 21(1):39. PubMed ID: 35287684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular Mechanisms and New Treatment Paradigm for Atrial Fibrillation.
    Sirish P; Li N; Timofeyev V; Zhang XD; Wang L; Yang J; Lee KS; Bettaieb A; Ma SM; Lee JH; Su D; Lau VC; Myers RE; Lieu DK; López JE; Young JN; Yamoah EN; Haj F; Ripplinger CM; Hammock BD; Chiamvimonvat N
    Circ Arrhythm Electrophysiol; 2016 May; 9(5):. PubMed ID: 27162031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atrial Fibrillation and Diabetes Mellitus: Dangerous Liaisons or Innocent Bystanders?
    Lorenzo-Almorós A; Casado Cerrada J; Álvarez-Sala Walther LA; Méndez Bailón M; Lorenzo González Ó
    J Clin Med; 2023 Apr; 12(8):. PubMed ID: 37109205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for a role of advanced glycation end products in atrial fibrillation.
    Raposeiras-Roubín S; Rodiño-Janeiro BK; Grigorian-Shamagian L; Seoane-Blanco A; Moure-González M; Varela-Román A; Álvarez E; González-Juanatey JR
    Int J Cardiol; 2012 Jun; 157(3):397-402. PubMed ID: 21652096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention and reversal of atrial fibrillation inducibility and autonomic remodeling by low-level vagosympathetic nerve stimulation.
    Sheng X; Scherlag BJ; Yu L; Li S; Ali R; Zhang Y; Fu G; Nakagawa H; Jackman WM; Lazzara R; Po SS
    J Am Coll Cardiol; 2011 Feb; 57(5):563-71. PubMed ID: 21272747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.